Robinhood Asset Management’s ResMed RMD Stock Holding History

Robinhood Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,151	Closed	-$707K	–	97
2026 Q1	$707K	Buy	3,151 +529	+20%	+$132K	0.05%	68
2025 Q4	$632K	Buy	+2,622	New	+$671K	0.05%	71

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Robinhood Asset Management's RMD Position: Q2 2026 in Review

Robinhood Asset Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 3,151 shares — an estimated $707K sold.

Robinhood Asset Management first reported a position in RMD in Q4 2025 and held it in 2 quarters. The position peaked at $707K in Q1 2026. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Robinhood Asset Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Robinhood Asset Management sold 3,151 ResMed shares in Q2 2026, an estimated $707K.
Robinhood Asset Management first reported a position in ResMed in Q4 2025 and held it in 2 quarters.
Robinhood Asset Management's ResMed position peaked at $707K in Q1 2026.
880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Robinhood Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.